John McCoy
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
John A. McCoy is President & Treasurer at Cardiovascular Systems, Inc. and Vice President-Finance & Controller at Abbott Laboratories since 2023.
Formerly, Mr. McCoy was Senior Vice President & Controller at Baxalta, Inc. from 2015 to 2016.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-03-2026 | 24.686 ( 0% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CARDIOVASCULAR SYSTEMS, INC. | President | - |
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | 01-09-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BAXALTA INC | Comptroller/Controller/Auditor | 01-01-2016 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Develops medical devices for treating peripheral and coronary artery disease | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau